Press
F-CRIN
26 May 2026
-
Welcome to I-REIVAC's website !
To download the network's presentation leaflet, click below.
-
The CoV-IREIVAC platform of volunteers
CoV-IREIVAC is a unique, national, online volunteer platform dedicated to the evaluation of vaccines and monoclonal antibodies to prevent infectious diseases.
-
Take part of I-REIVAC's community of volunteers !
To find more information, go straight to CoV-IREIVAC's website.
I-REIVAC, a network dedicated to clinical research in vaccinology
Created in 2007, the I-REIVAC network (Innovative Clinical REsearch Network in VACcinology) was certified an F-CRIN Network of Excellence in 2014.
The network's scope focuses on the evaluation of vaccines and the use of monoclonal antibodies for preventive purposes in healthy volunteers and "specific populations" (immunocompromised individuals, the elderly, pregnant women, patients with comorbidities, etc.) in the field of infectious diseases.
Coordinated by Professor Odile Launay, an infectious disease specialist and vaccinology researcher at the Cochin Hospital in Paris, and Professor Eric Tartour, an immunologist at the HEGP Hospital in Paris, the network conducts clinical research projects: clinical trials (phases 1 to 3), real-life studies (phase 4), large-scale epidemiological studies (cohorts, cross-sectional studies, etc.) and also develops a social science approach, including on the acceptability of vaccination programs.
30
Clinical centres
Associated with a network of Biological Resource Centres
11
Immunology laboratories
>30
Ongoing clinical studies
>55 000
Volunteers registered on the CoV-IREIVAC platform
Map of I-REIVAC's members
Locate I-REIVAC's coordination headquarters as well as all the centres part of the network.
News
Press
F-CRIN
07 April 2026
News
F-CRIN
12 March 2026
